Acadia Healthcare Q4 2024 revenue $774.2M (+4.2%); adj. EPS $0.64; announces $300M buyback

Acadia Healthcare Company, Inc.

2024-FY EPS reported $2.78 revenue$3,153,963,000

Q4 net income $32.6M ($0.35 diluted EPS); adjusted income $59.2M ($0.64 diluted EPS).
Same-facility revenue +4.7% YoY on patient days +3.2% and revenue per patient day +1.4%.
Adjusted EBITDA $153.1M, including $14.3M professional liability reserve adjustment and $5.0M facility closure impact.
Added 577 newly licensed beds in Q4; completed ~1,300 newly constructed beds in FY2024.
Board authorized new $300M share repurchase program; FY2025 and Q1 2025 guidance provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.